DEC 30, 2020 10:30 AM PST

Gene Therapy Cures Mice of Deafness

WRITTEN BY: Annie Lennon

Currently, around half a billion people suffer from hearing loss around the world. In about half of these cases, genetic mutations of one or more of around 100 different genes are thought to be the cause. Gene therapies thus hold obvious potential as a cure. And now, researchers from Tel Aviv University in Israel have successfully completed animal studies on a novel genetic-based treatment for the condition.

For the study, the researchers focused on genetic deafness caused by a mutation of the gene SYNE4. A rare condition, children who inherit the gene from both parents are born with normal hearing that gradually becomes weaker over the course of their childhood. This happens as the mutation causes mislocalization of cell nuclei in the hair cells inside the inner ear's cochlea (used to detect sound), and eventually leads to their degeneration and death. 

To see whether they could stop this process in its tracks, the researchers created a harmless synthetic virus capable of delivering a normal version of the SYNE4 gene to cells. They then injected this variant into the inner ear of mice carrying the mutated version soon after birth so it could enter their hair cells. 

As the mice grew older, the researchers monitored their hearing with physiological and behavioral tests. In the end, they found that mice treated soon after birth developed normal hearing with a sensitivity practically the same as that of healthy mice born without the mutation. Given this success, the researchers are now developing similar therapies that may be used for other mutations that cause deafness. 

"This is an important study that shows that inner ear gene therapy can be effectively applied to a mouse model of SYNE4 deafness to rescue hearing. The magnitude of hearing recovery is impressive.” says Professor Wade Chien from Johns Hopkins School of Medicine. 

“This study is a part of a growing body of literature showing that gene therapy can be successfully applied to mouse models of hereditary hearing loss, and it illustrates the enormous potential of gene therapy as a treatment for deafness."

 

Sources: Medical NewsTel Aviv University 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
OCT 29, 2020
Cardiology
Treating Cardiovascular Calcification at the Source
OCT 29, 2020
Treating Cardiovascular Calcification at the Source
The term cardiovascular disease covers a broad array of health problems. Everyone tends to think of heart attacks or hyp ...
NOV 25, 2020
Immunology
The History of Vaccines
NOV 25, 2020
The History of Vaccines
Everyone worldwide is sitting with anticipation, waiting for the right vaccine candidate for the coronavirus outbreak, h ...
NOV 24, 2020
Drug Discovery & Development
MMR Vaccine Shows Promise Against COVID-19
NOV 24, 2020
MMR Vaccine Shows Promise Against COVID-19
Researchers have found that a vaccine used for mumps, measles, and rubella (MMR) may be effective in protecting against ...
DEC 01, 2020
Immunology
Scar-Free Healing Starts With Mobilizing the Immune System
DEC 01, 2020
Scar-Free Healing Starts With Mobilizing the Immune System
Thanks to a new hydrogel biomaterial developed by researchers at Duke University, we are one step closer to the holy gra ...
DEC 20, 2020
Drug Discovery & Development
Antifungal Drug May Treat Cystic Fibrosis
DEC 20, 2020
Antifungal Drug May Treat Cystic Fibrosis
A fungal-targeting drug was shown to improve symptoms of cystic fibrosis particularly key biomarkers in lung tissue cult ...
DEC 25, 2020
Drug Discovery & Development
Class of Antibiotics May Target Resistant Bacteria
DEC 25, 2020
Class of Antibiotics May Target Resistant Bacteria
Researchers found a new class of antibiotics for combatting antimicrobial resistance (AMR). Learn more about antibiotic ...
Loading Comments...